Organigram (TSE:OGI) Trading Down 1.3% – Here’s Why

Organigram Holdings Inc. (TSE:OGIGet Free Report) fell 1.3% on Tuesday . The stock traded as low as C$2.33 and last traded at C$2.34. 97,020 shares changed hands during trading, a decline of 58% from the average session volume of 231,158 shares. The stock had previously closed at C$2.37.

Organigram Trading Down 1.3%

The company has a market capitalization of C$314.64 million, a P/E ratio of -12.06, a PEG ratio of 0.42 and a beta of 2.11. The business has a fifty day moving average of C$2.33 and a 200-day moving average of C$2.28. The company has a debt-to-equity ratio of 3.07, a quick ratio of 2.62 and a current ratio of 3.36.

Insider Buying and Selling at Organigram

In other Organigram news, insider Paolo De Luca sold 12,007 shares of the business’s stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of C$2.49, for a total transaction of C$29,897.43. Following the completion of the sale, the insider directly owned 35,768 shares of the company’s stock, valued at approximately C$89,062.32. The trade was a 25.13% decrease in their position. Also, insider Helen Martin sold 12,848 shares of the company’s stock in a transaction on Tuesday, October 21st. The stock was sold at an average price of C$2.49, for a total value of C$31,991.52. Following the sale, the insider owned 47,511 shares of the company’s stock, valued at C$118,302.39. This trade represents a 21.29% decrease in their position. In the last three months, insiders have sold 161,555 shares of company stock worth $385,351. 31.32% of the stock is currently owned by corporate insiders.

Organigram Company Profile

(Get Free Report)

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

See Also

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.